<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Bioeng. Biotechnol.</journal-id>
<journal-title>Frontiers in Bioengineering and Biotechnology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Bioeng. Biotechnol.</abbrev-journal-title>
<issn pub-type="epub">2296-4185</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1365870</article-id>
<article-id pub-id-type="doi">10.3389/fbioe.2024.1365870</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Bioengineering and Biotechnology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Genetically stable kill-switch using &#x201c;demon and angel&#x201d; expression construct of essential genes</article-title>
<alt-title alt-title-type="left-running-head">Kato and Mori</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fbioe.2024.1365870">10.3389/fbioe.2024.1365870</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Kato</surname>
<given-names>Yusuke</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1562687/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mori</surname>
<given-names>Hirotada</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Institute of Agrobiological Sciences</institution>, <institution>National Agriculture and Food Research Organization (NARO)</institution>, <addr-line>Tsukuba</addr-line>, <addr-line>Ibaraki</addr-line>, <country>Japan</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Laboratory of Systems Microbiology</institution>, <institution>Data Science Center</institution>, <institution>Nara Institute of Science and Technology</institution>, <addr-line>Ikoma</addr-line>, <addr-line>Nara</addr-line>, <country>Japan</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/91782/overview">Pasquale Stano</ext-link>, University of Salento, Italy</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/541084/overview">Mimi Cho Yung</ext-link>, Lawrence Livermore National Security, United States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/602777/overview">Diego Bonatto</ext-link>, Departamento de Biologia Molecular e Biotecnologia da UFRGS, Brazil</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/944914/overview">R. Adam Thompson</ext-link>, LanzaTech, United States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Yusuke Kato, <email>kato@affrc.go.jp</email>
</corresp>
<fn fn-type="present-address" id="fn1">
<label>
<sup>&#x2020;</sup>
</label>
<p>
<bold>Present address:</bold> Hirotada Mori, Innovation laboratory of Systems Microbiology and Synthetic Biology, Institute of Animal Science, Guangdong Academy of Agricultural Sciences. Guangzhou, Guangdong, China</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>28</day>
<month>02</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>12</volume>
<elocation-id>1365870</elocation-id>
<history>
<date date-type="received">
<day>05</day>
<month>01</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>13</day>
<month>02</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Kato and Mori.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Kato and Mori</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Genetic instability of synthetic genetic devices is a key obstacle for practical use. This problem is particularly critical in kill-switches for conditional host killing. Here, we propose a genetically stable kill-switch based on a &#x201c;demon and angel&#x201d; expression construct of a toxic essential gene. The kill-switch conditionally overexpresses the toxic essential gene. Additionally, the identical essential gene is deleted in the genome. The essential gene is expressed at a low level to maintain host survival in the OFF state and kills the host by the overexpression in the ON state. The single expression construct is responsible for both killing the hosts and maintaining viability, reducing the emergence of loss-of-function mutants. We constructed the kill-switch using the toxic essential gene encoding tyrosyl-tRNA synthetase, <italic>tyrS</italic>, in <italic>Escherichia coli</italic>. The bacteria harboring the kill-switch were conditionally suicidal over 300 generations. Toxic overexpression of essential genes has also been found in other organisms, suggesting that the &#x201c;demon and angel&#x201d; kill switch is scalable to various organisms.</p>
</abstract>
<kwd-group>
<kwd>genetic stability</kwd>
<kwd>biological containment</kwd>
<kwd>toxic overexpression</kwd>
<kwd>genetic devices</kwd>
<kwd>ASKA library</kwd>
</kwd-group>
<contract-sponsor id="cn001">Japan Society for the Promotion of Science<named-content content-type="fundref-id">10.13039/501100001691</named-content>
</contract-sponsor>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Synthetic Biology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>1 Introduction</title>
<p>Synthetic gene circuits for bioengineering purposes are usually not essential for host survival, but rather a burden (<xref ref-type="bibr" rid="B6">Boo et al., 2019</xref>; <xref ref-type="bibr" rid="B43">Son et al., 2021</xref>; <xref ref-type="bibr" rid="B24">Kumar and Hasty, 2023</xref>). Therefore, the synthetic gene circuits are genetically unstable since loss-of-function mutants have a higher fitness. This problem is a critical obstacle to the practical application of synthetic biology. Kill-switch is a genetic device that conditionally kills host cells (<xref ref-type="bibr" rid="B34">Moe-Behrens et al., 2013</xref>). The kill-switch is used as a core component in biological containment and density control systems (<xref ref-type="bibr" rid="B20">Kato, 2015</xref>; <xref ref-type="bibr" rid="B9">Chan et al., 2016</xref>; <xref ref-type="bibr" rid="B24">Kumar and Hasty, 2023</xref>). The application of genetically engineered microorganisms with biological containment in the open environments, such as live vaccines and on-site bioremediation, is considered revolutionary in the bioindustry (<xref ref-type="bibr" rid="B37">Piraner et al., 2017</xref>; <xref ref-type="bibr" rid="B18">Ishikawa et al., 2021</xref>; <xref ref-type="bibr" rid="B41">Sebesta et al., 2022</xref>; <xref ref-type="bibr" rid="B35">Nagasawa et al., 2024</xref>). In addition, highly efficient microbial production with precise growth control, particularly in multi-cell systems, is also a useful application (<xref ref-type="bibr" rid="B31">Miano et al., 2020</xref>; <xref ref-type="bibr" rid="B21">Kato, 2021</xref>). Because the kill-switches contain toxic genes, they harm the cells even in the OFF-state by leakage toxic expression and are therefore particularly prone to genetic instability, allowing loss-of-function mutants to emerge and predominate through passaging (<xref ref-type="bibr" rid="B45">Stirling et al., 2017</xref>). To construct a useful kill-switch, it is essential to resolve the genetic instability.</p>
<p>To date, several methods have been proposed to reduce the genetic instability of kill-switches. Strategies fall into two major categories. One is to reduce the frequency of mutations that cause loss-of-function. Methods include removal of transposable elements and IS elements (<xref ref-type="bibr" rid="B50">Umenhoffer et al., 2010</xref>; <xref ref-type="bibr" rid="B46">Su&#xe1;rez et al., 2017</xref>; <xref ref-type="bibr" rid="B16">Geng et al., 2019</xref>), deletion of mutagenic genes (<xref ref-type="bibr" rid="B11">Deatherage et al., 2018</xref>), exclusion of repetitive sequences (<xref ref-type="bibr" rid="B17">Hossain et al., 2020</xref>) and hosting of reduced genome cells (<xref ref-type="bibr" rid="B9">Chan et al., 2016</xref>). Maintenance using toxin-antitoxin systems (<xref ref-type="bibr" rid="B13">Fedorec et al., 2019</xref>), mobile plasmids (<xref ref-type="bibr" rid="B28">Lopatkin et al., 2017</xref>) and integration into the genome (<xref ref-type="bibr" rid="B29">Mandell et al., 2015</xref>) have been effective in preventing the loss of kill-switches encoded on plasmids. Removal of mutants by periodic renewal of the cell population is also a promising solution (<xref ref-type="bibr" rid="B27">Liao et al., 2019</xref>). The other is eliminating the fitness advantage of loss-of-function mutants. Minimizing unintended toxicity in the OFF state mitigates the reduced fitness of cells harboring the kill-switch (<xref ref-type="bibr" rid="B45">Stirling et al., 2017</xref>; <xref ref-type="bibr" rid="B38">Rottinghaus et al., 2022</xref>). Linking the functional expression of essential genes to kill-switches can reduce the fitness of mutants (<xref ref-type="bibr" rid="B51">Yang et al., 2013</xref>; <xref ref-type="bibr" rid="B5">Blazejewski et al., 2019</xref>). These methods assume that the emergence of loss-of-function mutations in kill-switches is inevitable and attempt only to minimize the impact of the mutations.</p>
<p>Here, we propose a novel principle to construct a genetically stable kill-switch, that is theoretically intolerant to mutations, using a &#x201c;demon and angel&#x201d; essential gene expression construct (<xref ref-type="fig" rid="F1">Figure 1</xref>). In the bacterium <italic>Escherichia coli</italic>, we cloned the all ORFs of protein-coding genes in the ASKA plasmid library (<xref ref-type="bibr" rid="B23">Kitagawa et al., 2005</xref>). The cloned ORF can be overexpressed in the presence of IPTG by the coliphage T5 promoter with <italic>lacO</italic> operators (<xref ref-type="bibr" rid="B7">Bujard et al., 1987</xref>). Interestingly, overexpression of the ORFs was often toxic to the host (<xref ref-type="bibr" rid="B23">Kitagawa et al., 2005</xref>). These toxic ORFs include many essential genes. To construct the kill-switch, a plasmid conditionally overexpressing the toxic essential gene is transformed into the host. The ASKA plasmids meet this requirement. Meanwhile, the identical essential gene is disrupted in the genome. Therefore, the resulting bacteria must supply the essential gene product from the ASKA plasmid. The overexpression is suppressed in the absence of IPTG (OFF state), but a small amount of product is produced due to the leakage expression (<xref ref-type="bibr" rid="B26">Lanzer and Bujard, 1988</xref>), maintaining the bacteria in survival and growth. However, in the presence of IPTG (ON state), the essential gene is overexpressed and kills the host bacteria. In this kill-switch, a single expression construct provides not only the host-killing toxin but also the essential gene product for survival, predicting that loss-of-function mutations are largely prevented. In addition, leakage expression of toxins, which is a cause of genetic instability in conventional kill switches, is not a problem because such low-level expression is essential for survival, not poisonous. In this study, we demonstrate the principle of the &#x201c;demon and angel&#x201d; kill-switch using the ASKA plasmids in <italic>E. coli.</italic>
</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Kill-switch using the &#x201c;demon and angel&#x201d; expression construct of an essential gene. A schematic diagram is shown. <italic>P</italic>
<sub>
<italic>T5</italic>
</sub>, the coliphage T5 promoter. The genes shown at the top and the bottom of each construct are the original essential genes in the genome and the synthetic overexpression constructs in the plasmid, respectively. The graph shows the relation between the expression level of the essential gene and the level of fitness. The red triangle represents the expression level by the indicated construct.</p>
</caption>
<graphic xlink:href="fbioe-12-1365870-g001.tif"/>
</fig>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>2 Materials and methods</title>
<sec id="s2-1">
<title>2.1 Bacterial strains</title>
<p>
<italic>E. coli</italic> K-12, strain AG1 [<italic>recA1 endA1 gyrA96 thi-1 hsdR17</italic> (<italic>rKmK&#xfe;</italic>) <italic>supE44 relA1</italic>] harboring ASKA&#x2b; and ASKA-plasmid libraries, W3110, and W3110&#xa0;ts 29-13 were obtained from the National BioResource Project (NIG, Japan): <italic>E. coli</italic> (<ext-link ext-link-type="uri" xlink:href="https://shigen.nig.ac.jp/ecoli/strain/">https://shigen.nig.ac.jp/ecoli/strain/</ext-link>). BL21-AI [F<sup>&#x2212;</sup>
<italic>omp</italic>T <italic>hsd</italic>S<sub>B</sub> (r<sub>B</sub>
<sup>&#x2212;</sup> m<sub>B</sub>
<sup>&#x2212;</sup>)<italic>gal dcm ara</italic>B::T7RNAP-<italic>tet</italic>A] was purchased commercially (ThermoFisher Scientific, MA, United States).</p>
</sec>
<sec id="s2-2">
<title>2.2 Bacterial culture and transformation</title>
<p>LB medium (1% BactoTriptone, 0.5% Bacto Yeast Extract, 1% NaCl) was used to culture all <italic>E. coli</italic> strains. Antibiotics (chloramphenicol 50&#xa0;mg/L, kanamycin 25&#xa0;mg/L, and tetracycline 1.25&#xa0;mg/L) were added as needed. Liquid culture was performed in an air incubator with shaking (180&#xa0;rpm). To prepare solid media, 2% agar was added. Bacteria were incubated at 37&#xb0;C unless otherwise noted. Bacterial transformation was performed by electroporation using a Gene Pulser II&#x2122; electroporator (Bio-Rad Laboratories, CA, United States).</p>
</sec>
<sec id="s2-3">
<title>2.3 Evaluation for toxic overexpression</title>
<p>The procedure for preliminary toxicity and GFP-fluorescence evaluation for all ORFs using ASKA&#x2b; plasmid library has been described previously (<xref ref-type="bibr" rid="B23">Kitagawa et al., 2005</xref>). For quantitative assays, overnight cultures of <italic>E. coli</italic> harboring the ASKA-plasmid encoding the tested ORFs were used. The cultures diluted 10 to 10<sup>3</sup>-fold were inoculated 250&#xa0;&#x3bc;L onto solid medium containing 1&#xa0;mM IPTG and chloramphenicol, a selection marker for ASKA-, and surviving colonies were counted. The total number of bacteria was determined by inoculating 10<sup>6</sup>-fold diluted cultures onto a solid medium without IPTG. The toxicity due to overexpression was assessed by the survivor frequency (survivors/total CFU).</p>
</sec>
<sec id="s2-4">
<title>2.4 Preparation of BL21-AI [<italic>tyrS</italic>
<sup>&#x2212;</sup>; ASKA-(<italic>tyrS</italic>)]</title>
<p>The ASKA-clone encoding <italic>tyrS</italic> was isolated from AG1 carrying this plasmid using the Qiagen Plasmid Midi (Qiagen Inc., CA, United States) and transformed into BL21-AI. The <italic>tyrS</italic> in the genome of the resulting BL21-AI [<italic>tyrS</italic>
<sup>
<italic>&#x2b;</italic>
</sup>; ASKA-(<italic>tyrS</italic>)] strain was substituted with a knock-out cassette containing the neomycin resistance gene using &#x3bb;Red recombinase (<xref ref-type="bibr" rid="B10">Datsenko and Wanner, 2000</xref>). Among individual colonies resistant to both chloramphenicol and kanamycin, clones with successful substitution were identified by PCR using the genomic DNA as a template. Finally, the deletion of <italic>tyrS</italic> was directly confirmed by sequencing the <italic>tyrS</italic> locus using the Illumina sequencing, as detailed below.</p>
</sec>
<sec id="s2-5">
<title>2.5 Passage test</title>
<p>Plasmid loss was tested for BL21-AI [<italic>tyrS</italic>
<sup>
<italic>-</italic>
</sup>; ASKA-(<italic>tyrS</italic>)] and the control parent strain, BL21-AI [<italic>tyrS</italic>
<sup>
<italic>&#x2b;</italic>
</sup>; ASKA-(<italic>tyrS</italic>)]. Every 24&#xa0;h, the bacteria were diluted 10<sup>3</sup>-fold (1&#xa0;&#x3bc;L/1&#xa0;mL fresh LB medium without selection marker antibiotics) and incubated again at 25&#xb0;C. This dilution and reculturing was repeated 12 times, approximately 120 generations. On inoculation into a new medium, an aliquot of the culture was withdrawn, diluted 10<sup>6</sup>-fold, and inoculated (250&#xa0;&#x3bc;L) onto solid medium. Sixty-four colonies were selected and inoculated on solid medium containing chloramphenicol to determine plasmid maintenance.</p>
<p>To verify genetic stability, bacteria were cultured in the presence of chloramphenicol and kanamycin which prevent contamination by non-tested bacteria during the 1 month long serial cultures. Dilution and reculturing procedures were identical to those used in the plasmid loss test. On inoculation for reculturing, an aliquot of the cultures was withdrawn, diluted 10-fold, and inoculated (250&#xa0;&#x3bc;L) onto solid medium containing 5&#xa0;mM IPTG. Surviving colonies were counted after overnight incubation. The total number of bacteria was also measured by inoculating 10<sup>6</sup>-fold diluted cultures on IPTG-free solid medium.</p>
</sec>
<sec id="s2-6">
<title>2.6 Genome sequencing</title>
<p>The procedure for genome sequencing has been described previously (<xref ref-type="bibr" rid="B22">Kato, 2023</xref>). Briefly, total DNA, including genomic and plasmid DNAs, was extracted using the DNeasy Blood and Tissue Kit (Qiagen). After checking the integrity of the extracted DNA, sequencing libraries were prepared using a TruSeq DNA PCR-free Sample Preparation Kit (Illumina, Inc., San Diego, CA, United States). The purified libraries were subjected to paired-end (2 &#xd7; 150&#xa0;bp) sequencing by Macrogen using the NovaSeq6000 platform. Raw reads were trimmed to remove adapter sequences, mapped to the <italic>E. coli</italic> BL21-AI (NZ_CP047231.1) and ASKA-(<italic>tyrS</italic>) reference sequence using BWA-MEM v0.7.17. Variants (SNPs and small INDELs) were identified using Samtools. Variant functional annotation was performed with SnpEff v.5.0e (<ext-link ext-link-type="uri" xlink:href="https://pcingola.github.io/SnpEff/">https://pcingola.github.io/SnpEff/</ext-link>).</p>
</sec>
<sec id="s2-7">
<title>2.7 RNA-seq</title>
<p>Bacterial samples were homogenized using a Multi-beads Shocker<sup>&#xae;</sup> (Yasuikikai, Osaka, Japan) at 1,500&#xa0;rpm for 2&#xa0;min. Total RNA was extracted using the RNeasy Mini Kit and the QIAcube Connect Extraction System (Qiagen). The concentration of the total RNA samples was determined using the Synergy LX multimode reader (BioTek, VT, United States) and the QuantiFluor RNA System (Promega, WI, United States). The RNA quality was evaluated using the 5,200 Fragment Analyzer System and the Agilent HS RNA Kit (Agilent Technologies, Inc., CA, United States). After the ribosomal RNA depletion with the RiboPOOL kit (siTOOLs Biotech GmbH, Planegg, Germany), the cDNA libraries were prepared using the MGIEasy RNA Directional Library Prep Kit (MGI-Tech, Shenzhen, China). The concentration of libraries was determined as described above. A library quality check was performed using the dsDNA 915 reagent kit (Agilent Technologies) and the Fragment Analyzer. Circularized DNA and DNA nanoballs were prepared using the MGIEasy circularization kit and the DNBSEQ-G400RS high-throughput sequencing kit (MGI-Tech). The DNBs were sequenced using the DNBSEQ-G400 (MGI-Tech). The cutadapt (ver. 4.0) and sickle tools (ver. 1.33) were used to remove adapter sequences and low-quality sequence reads. The resulting reads were mapped using Bowtie 2 (ver. 2.5.0) to the <italic>E. coli</italic> BL21-AI genome (CP047231.1) and the plasmid ASKA-(<italic>tyrS</italic>). The mapped reads were quantified with FeatureCounts (ver.2.0.3). The row counts were normalized using the transcripts-per-million (TPM) method. The expression level was evaluated relative to <italic>gltA</italic>, a constitutively expressed gene (<xref ref-type="bibr" rid="B12">Denger et al., 2014</xref>).</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>3 Results</title>
<sec id="s3-1">
<title>3.1 Screening of &#x201c;toxic&#x201d; essential genes</title>
<p>The ASKA plasmid is a multi-copy plasmid containing the colE1 origin (<xref ref-type="bibr" rid="B23">Kitagawa et al., 2005</xref>). There are two types of ASKA plasmid: ASKA&#x2b; in which <italic>gfp</italic> is fused at the 3&#x2019; terminal end of the ORF, and ASKA-which excludes the <italic>gfp</italic>. We examined growth and GFP expression of <italic>E. coli</italic> AG1 harboring ASKA&#x2b; plasmids in overexpression induction with 1&#xa0;mM IPTG (<xref ref-type="sec" rid="s10">Supplementary Table S1</xref>). Total 4,269 ORFs were tested. Growth inhibition was observed in 3,301 ORFs (77%), of which 2,149 (50%) were severely inhibited with almost no growth, as previously reported (<xref ref-type="bibr" rid="B23">Kitagawa et al., 2005</xref>) (<xref ref-type="fig" rid="F2">Figure 2</xref>). Of the ORFs that severely inhibited growth, 156 were essential genes. This represents 52% of all 300 essential genes. Some of these severely growth inhibitory essential genes did not interfere with GFP expression, suggesting that the host viability is well maintained, i.e., &#x201c;bacteriostatic,&#x201d; presumably. By contrast, 112 of the highly growth inhibitory essential genes expressed little or no GFP, indicating a bactericidal or severely damaging effect. Thus, there are more than 10<sup>2</sup> essential genes that are strongly harmful upon overexpression.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Screening for toxic essential genes in the overexpression. The ASKA&#x2b; plasmid library containing 4269&#xa0;<italic>E. coli</italic> W3110 ORFs was screened. Left column is cited from <xref ref-type="bibr" rid="B23">Kitagawa et al., 2005</xref> with some modifications. Survivor frequencies were evaluated using the ASKA-plasmid library to avoid the effect of GFP-tag. The value indicated at the top of each column is the total number.</p>
</caption>
<graphic xlink:href="fbioe-12-1365870-g002.tif"/>
</fig>
<p>For the 112 essential genes that exhibited both strong growth inhibition and suppression of GFP expression, we evaluated the survivor frequency upon overexpression (<xref ref-type="sec" rid="s10">Supplementary Table S2</xref>). To avoid the effects of <italic>gfp</italic>-tag, the ASKA-plasmids were used. The survivor frequency showed significant variability. For example, with <italic>dnaX</italic> and <italic>tilS</italic>, no colonies were detected in the presence of 1&#xa0;mM IPTG after inoculating around 10<sup>7</sup>&#xa0;CFU (<xref ref-type="sec" rid="s10">Supplementary Table S2</xref>; <xref ref-type="sec" rid="s10">Supplementary Figure S2</xref>). In contrast, some survivors were detected in other ORFs such as <italic>murG</italic> and <italic>ftsE</italic>. There were 28 (25%) ORFs that showed a survival frequency of &#x3c;30 &#xd7; 10<sup>&#x2212;6</sup>. Of these, 16 were cytoplasmic proteins, 9 were integral membrane proteins, and 3 were membrane anchored proteins (<xref ref-type="sec" rid="s10">Supplementary Table S2</xref>).</p>
</sec>
<sec id="s3-2">
<title>3.2 Realization of the &#x201c;demon and angel&#x201d; kill-switch</title>
<p>To realize the &#x201c;demon and angel&#x201d; kill-switch, we examined which essential gene would be a suitable model. The kill-switch must provide a small amount of functional product by leakage expression in the OFF state to maintain host viability. Membrane proteins are often difficult to express functionally and injure the host (<xref ref-type="bibr" rid="B30">Mathieu et al., 2019</xref>). Therefore, we decided to select a candidate essential gene among genes encoding cytoplasmic proteins. We focused on aminoacyl-tRNA synthetase (aaRS) genes. A total of 26 aaRS genes, including 22 essential genes, were found in the ASKA&#x2b; library. Of the 24 genes tested, 23 showed toxicity upon overexpression (<xref ref-type="sec" rid="s10">Supplementary Table S3</xref>). Nine genes, <italic>pheT, leuS, tyrS, ileS, tilS, proS, argS, glyS</italic> and <italic>poxA</italic>, were highly growth inhibitory with no GFP expression. Among these toxic aaRS genes, we focused on the essential gene encoding the tyrosyl-tRNA synthetase <italic>tyrS</italic> (<xref ref-type="bibr" rid="B33">Mirande, 1991</xref>). The survivor frequency of AG1 [ASKA-(<italic>tyrS</italic>)] upon overexpression with 1&#xa0;mM IPTG was only 22.5 &#xd7; 10<sup>&#x2212;6</sup>, indicating potent toxicity (<xref ref-type="sec" rid="s10">Supplementary Tables S2, S3</xref>). After the exposure to 5&#xa0;mM IPTG for 1&#xa0;h or less, AG1 [ASKA-(<italic>tyrS</italic>)] rapidly and irreversibly lost the ability to form colonies, suggesting that the effect of <italic>tyrS</italic> overexpression is bactericidal and suitable for host-killing (<xref ref-type="sec" rid="s10">Supplementary Figure S3</xref>). The availability of temperature-sensitive mutants and the presumed low impact of genomic gene deletion, as described below, are advantages for the application of <italic>tyrS</italic> to a proof-of-concept experiment of the kill-switch.</p>
<p>
<italic>E. coli</italic> W3110&#xa0;ts 29-13 strain is a temperature-sensitive mutant of <italic>tyrS</italic> (<ext-link ext-link-type="uri" xlink:href="https://shigen.nig.ac.jp/ecoli/strain/locale/change?lang=en">https://shigen.nig.ac.jp/ecoli/strain/locale/change?lang&#x3d;en</ext-link>). This strain shows normal growth at 30&#xb0;C but fails to form colonies at 42&#xb0;C (<xref ref-type="sec" rid="s10">Supplementary Figure S4A</xref>). We transformed the plasmid ASKA-(<italic>tyrS</italic>) into this strain. The resulting strain, W3110&#xa0;ts 29-13 [ASKA-(<italic>tyrS</italic>)], recovered colony formation at 42&#xb0;C in the absence of IPTG, suggesting that ASKA-(<italic>tyrS</italic>) can supply TyrS at levels required for host survival and proliferation by leakage expression (<xref ref-type="sec" rid="s10">Supplementary Figure S4A</xref>). No colonies were observed in the presence of 3&#xa0;mM IPTG at both 30&#xb0;C and 42&#xb0;C, suggesting that <italic>tyrS</italic> overexpression kills the host (<xref ref-type="sec" rid="s10">Supplementary Figure S4B</xref>). These results suggest that the &#x201c;demon and angel&#x201d; kill-switch using <italic>tyrS</italic> is feasible to construct, as we confirmed the rescue of host survival and growth by leakage expression in the OFF state and the host-killing by overexpression in the ON state.</p>
<p>Next, we constructed the kill-switch in a <italic>tyrS</italic> deletion mutant strain. <italic>tyrS</italic> is part of the <italic>pdxH-tyrS-pdxY</italic> operon (<xref ref-type="bibr" rid="B25">Lam and Winkler, 1992</xref>; <xref ref-type="bibr" rid="B52">Yang et al., 1998</xref>). <italic>pdxH</italic> and <italic>pdxY</italic> are non-essential genes, suggesting that disruption of the <italic>pdxH-tyrS-pdxY</italic> operon by <italic>tyrS</italic> deletion is unlikely to impair the function of other essential genes (<xref ref-type="bibr" rid="B49">Tramonti et al., 2021</xref>). First, we transformed ASKA-(<italic>tyrS</italic>) into the unmodified BL21-AI to obtain BL21-AI [<italic>tyrS</italic>
<sup>
<italic>&#x2b;</italic>
</sup>; ASKA-(<italic>tyrS</italic>)] (<xref ref-type="fig" rid="F3">Figure 3A</xref>) (<xref ref-type="bibr" rid="B4">Bhawsinghka et al., 2020</xref>). The ORF of <italic>tyrS</italic> in the genome was subsequently deleted by substituting the neomycin resistance gene. The deletion was confirmed by genome sequencing. The resulting BL21-AI [<italic>tyrS</italic>
<sup>
<italic>-</italic>
</sup>; ASKA-(<italic>tyrS</italic>)] strain survived and grew in the absence of IPTG, presumably due to leakage expression of the plasmid <italic>tyrS</italic> (<xref ref-type="fig" rid="F3">Figures 3B, C</xref>). Meanwhile, BL21-AI [<italic>tyrS</italic>
<sup>
<italic>-</italic>
</sup>; ASKA-(<italic>tyrS</italic>)] was killed in the presence of IPTG, as well as BL21-AI [<italic>tyrS</italic>
<sup>
<italic>&#x2b;</italic>
</sup>; ASKA-(<italic>tyrS</italic>)].</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Genetic stability of the &#x201c;demon and angel&#x201d; kill-switch. <bold>(A)</bold> Genotype of the tested strains. BL21-AI was used as the parent strain. <italic>neo</italic>
<sup>
<italic>R</italic>
</sup>, neomycin resistance gene. ASKA plasmids contain several other genes including <italic>lacI</italic>
<sup>
<italic>q</italic>
</sup> and <italic>cat.</italic> <bold>(B)</bold> IPTG-sensitivity of BL21-AI carrying ASKA-(<italic>tyrS</italic>). Overnight cultures were diluted 10<sup>3</sup>-fold and inoculated onto LB-agar plates with or without 5&#xa0;mM IPTG. <bold>(C)</bold> IPTG-induced host killing. Bacterial viability was tested in the presence and absence of 3&#xa0;mM IPTG. P0 and P31, the BL21-AI [<italic>tyrS</italic>
<sup>
<italic>-</italic>
</sup>; ASKA-(<italic>tyrS</italic>)] population after 0 and 31 passages, respectively. <bold>(D)</bold> Passage test to evaluate the maintenance of the ASKA-plasmid encoding <italic>tyrS</italic>. Bacterial cultures were diluted 10<sup>3</sup>-fold for each passage. Each data point was obtained from a sample after 24&#xa0;h of incubation at 25&#xb0;C. Bacteria harboring the plasmid were identified by their resistance to chloramphenicol, the selection marker for ASKA-. ASKA-(<italic>tyrS</italic>) plasmid was stably maintained in BL21-AI [<italic>tyrS</italic>
<sup>
<italic>-</italic>
</sup>; ASKA-(<italic>tyrS</italic>)] for &#x3e;12 passages whereas BL21-AI [<italic>tyrS</italic>
<sup>
<italic>&#x2b;</italic>
</sup>; ASKA-(<italic>tyrS</italic>)] lost the plasmid after six to seven passages. <bold>(E)</bold> Passage test to evaluate changes in the population frequency and bacterial density. Red and blue, IPTG-sensitive and -resistant bacteria, respectively. Green, bacterial density. Most of the bacteria remained IPTG-sensitive throughout the 30 passages. Survivor frequency showed complex changes. Bacterial density increased around the passage 18.</p>
</caption>
<graphic xlink:href="fbioe-12-1365870-g003.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>3.3 Genetic stability of <italic>tyrS</italic> kill-switch</title>
<p>Passage tests showed that BL21-AI [<italic>tyrS</italic>
<sup>
<italic>&#x2b;</italic>
</sup>; ASKA-(<italic>tyrS</italic>)] strain, which retains <italic>tyrS</italic> in the genome, lost the ASKA plasmid after six to seven passages (60&#x2013;70 generations) in the absence of plasmid selection marker chloramphenicol (<xref ref-type="fig" rid="F3">Figure 3D</xref>). In contrast, the ASKA plasmid was stably maintained for at least 120 generations in BL21-AI [<italic>tyrS</italic>
<sup>
<italic>-</italic>
</sup>; ASKA-(<italic>tyrS</italic>)] in which the genomic <italic>tyrS</italic> was deleted, suggesting that the plasmid <italic>tyrS</italic> is essential for survival in this strain.</p>
<p>BL21-AI [<italic>tyrS</italic>
<sup>
<italic>-</italic>
</sup>; ASKA-(<italic>tyrS</italic>)] was killed in the presence of IPTG. In a passage test, the IPTG sensitivity was preserved well through more than 30 passages, equivalent to about 300 generations (<xref ref-type="fig" rid="F3">Figures 3C, E</xref>, left panel). Interestingly, the survivor frequency showed complex changes over the generations, with a range of less than 30 &#xd7; 10<sup>&#x2212;6</sup>. Survivors isolated from passages 14 and 30 (P14R and P30R, respectively) were IPTG-resistant, indicating the emergence of loss-of-function mutants (<xref ref-type="fig" rid="F4">Figure 4A</xref>). Notably, most bacteria (&#x3e;99.997% at all time points of the 30 passages) maintained the kill-switch function and no rapid replacement with the loss-of-function mutants was observed (<xref ref-type="fig" rid="F3">Figure 3E</xref>, left panel).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Characterization of the IPTG-resistant mutants. We characterized two IPTG-sensitive strains, P0S and P31S, and two IPTG-resistant mutants, P14R and P30R, which were isolated in the passage test shown in <xref ref-type="fig" rid="F4">Figure 4</xref>. <bold>(A)</bold> IPTG sensitivity of the tested strains. P14R re-TF is the unmodified BL21-AI strain carrying the ASKA-plasmid isolated from P14R. <bold>(B)</bold> Relative expression of IPTG-inducible genes. A comprehensive analysis of gene expression was performed using RNA-seq. Red, red-striped, blue and blue-striped columns indicate P0S, P31S, P14R and P30R, respectively. The expression level was normalized to that of a constitutively expressed gene, <italic>gltA</italic>, citrate synthase. The values for each column were obtained from a single trial experiment. <bold>(C)</bold> Mutations found in the plasmid <italic>tyrS</italic> regulatory region. A schematic diagram of the <italic>tyrS</italic> regulatory region in the ASKA-plasmid is shown in the upper panel. The nucleotide sequences of the ASKA-plasmids isolated from P14R, P30R and P0S are aligned and shown in the lower panel. An asterisk indicates a conserved base.</p>
</caption>
<graphic xlink:href="fbioe-12-1365870-g004.tif"/>
</fig>
<p>To identify the IPTG-resistant mechanisms, the transcriptomes in the IPTG-sensitive strains isolated from passage 0 and 31, P0S and P31S, and the IPTG-resistant strains, P14R and P30R, were analyzed using RNA-seq. We found that the induction of the IPTG-regulated <italic>tyrS</italic> on the ASKA plasmid remarkably decreased in the IPTG-resistant strains although the IPTG-inducibility still remained partial (<xref ref-type="fig" rid="F4">Figure 4B</xref>). The <italic>tyrS</italic> induction ratio was 836.3, 499.1, 18.1 and 42.8, for P0S, P31S, P14R and P30R, respectively. Meanwhile, the basal expression of the plasmid <italic>tyrS</italic> was similar in both the IPTG-sensitive and resistant strains. Interestingly, the IPTG-induced expression level of the native IPTG-inducible genes in the genome, <italic>lacA</italic>, <italic>lacY</italic> and <italic>lacZ</italic>, was comparable between IPTG-sensitive and resistant strains. The basal expression of those genomic genes remarkably decreased in P14R and P30R although the expression of <italic>lacI</italic>, that negatively regulates the expression of the IPTG-inducible genes, was not clearly affected (<xref ref-type="sec" rid="s10">Supplementary Figure S5</xref>).</p>
<p>Next, we sequenced the total DNAs containing both genomic and plasmid DNA isolated from P0S, P14R and P30R, using Illumina sequencing. Severe mutations were found in the regulatory region of <italic>tyrS</italic> in the ASKA plasmid in P14R and P30R whose sequences were completely identical (<xref ref-type="fig" rid="F4">Figure 4C</xref>). The coliphage T5 promoter region was largely mutated, but the &#x2212;10 and &#x2212;35 regions were relatively conserved. Although <italic>lacO</italic>
<sub>
<italic>1</italic>
</sub> sequence embedded in the promoter was almost destroyed, <italic>lacO</italic>
<sub>
<italic>2</italic>
</sub> located between the promoter and the translation initiation site was completely conserved. The plasmid <italic>lacI</italic> was intact. Some additional genomic mutations were also detected in P14R and P30R (<xref ref-type="sec" rid="s10">Supplementary Table S4</xref>). Finally, the ASKA plasmid was extracted from P14R and transformed into unmodified BL21-AI. The resulting strain was IPTG-resistant, suggesting that the mutations on the plasmid are sufficient to cause loss of the kill-switch function (<xref ref-type="fig" rid="F4">Figure 4A</xref>).</p>
<p>Notably, the bacterial density clearly started to increase from around the passage 18 and grew to the passage 29-30 (<xref ref-type="fig" rid="F3">Figure 3E</xref>, right panel). The growth rate of P31S (doubling time &#x3d; 30.3&#xa0;min) was greater than those of P0S (41.5&#xa0;min) and P30R (33.3&#xa0;min).</p>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>4 Discussion</title>
<p>In this paper, we propose a novel principle for constructing kill-switches with high genetic stability. The kill-switch is based on a &#x201c;demon and angel&#x201d; essential gene expression construct on which both viability maintenance and host-killing depend. We constructed the kill-switch in <italic>E. coli</italic> using <italic>tyrS</italic> as a model. The viability maintenance essentiality in the OFF state and the host-killing in the ON state were maintained at least for 120 and 300 generations, respectively. Genes that are toxic upon overexpression have been reported not only in bacteria but also in various unicellular and multicellular eukaryotes (<xref ref-type="bibr" rid="B14">Freeman et al., 1995</xref>; <xref ref-type="bibr" rid="B3">Ben-Asouli et al., 2002</xref>; <xref ref-type="bibr" rid="B44">Sopko et al., 2006</xref>; <xref ref-type="bibr" rid="B19">Jiang et al., 2013</xref>). The application of the &#x201c;demon and angel&#x201d; kill switch should be scalable to various organisms.</p>
<p>CAMEOS has been proposed previously to ensure genetic stability of kill-switches by entangling the functional expression of essential and toxin genes by sequence overlapping (<xref ref-type="bibr" rid="B5">Blazejewski et al., 2019</xref>). However, some point mutations affect only the function of toxin and not that of the entangled essential gene. Use of bidirectional promoters to synchronize the expression of essential and toxin genes has been also reported, but similar limitation is also found (<xref ref-type="bibr" rid="B51">Yang et al., 2013</xref>). In the &#x201c;demon and angel&#x201d; kill switch, the toxin gene and the essential gene are completely identical involving the protein-coding and regulatory regions, so a mutation that affects the function of one should theoretically always affect the other, indicating the fundamental difference from the methods based on sequence overlapping.</p>
<p>Of the 300 essential genes in <italic>E. coli</italic>, 112 genes were associated with severely damaged phenotypes of massive growth inhibition and no GPF expression, suggesting that the essential genes with toxic overexpression phenotype are abundant. These toxic essential genes are candidate genetic parts to construct the &#x201c;demon and angel&#x201d; kill-switches.</p>
<p>Focusing on 24 aaRS genes, 23 genes were toxic, of which 9 genes exhibited the severely damaged phenotypes. The proper balance of the aaRS and the cognate tRNAs is critical in maintaining the fidelity of protein biosynthesis (<xref ref-type="bibr" rid="B47">Swanson et al., 1988</xref>). The production of many aaRSs is regulated via various negative autoregulatory mechanisms (<xref ref-type="bibr" rid="B36">Parker et al., 2020</xref>). The toxic-overexpression of some aaRS genes, including <italic>tyrS</italic>, have been previously reported (<xref ref-type="bibr" rid="B2">Bedouelle et al., 1990</xref>; <xref ref-type="bibr" rid="B8">Chalker et al., 1994</xref>; <xref ref-type="bibr" rid="B42">Skouloubris et al., 2003</xref>; <xref ref-type="bibr" rid="B1">Baick et al., 2004</xref>). In <italic>tyrS</italic>, the toxicity is directly correlated to the enzymatic activity (<xref ref-type="bibr" rid="B2">Bedouelle et al., 1990</xref>). This correlation is an advantage for use in the &#x201c;demon and angel&#x201d; kill-switch because mutations reducing toxicity always reduce essential enzymatic activity. The effect of <italic>tyrS</italic> overexpression was bactericidal, indicating its suitability for use in kill switches. Interestingly, most natural amino acid misincorporations by misacylated aminoacyl-tRNAs are tolerated (<xref ref-type="bibr" rid="B32">Min et al., 2003</xref>; <xref ref-type="bibr" rid="B39">Ruan et al., 2008</xref>). The informational disturbance caused by some aaRS overexpression could be more toxic than the misincorporation at the specific codons.</p>
<p>The bacteria carrying the <italic>tyrS</italic> kill-switch were killed in the presence of IPTG. For application to biological containment, we need to construct a kill-switch that causes the bacteria to be suicidal in the absence of a specific essential chemical or physical factor. Most simply, such a kill-switch could be constructed by substituting the <italic>lac</italic> system with a ligand-activated transcriptional repressor such as the Tet-off system (<xref ref-type="bibr" rid="B40">Schulte et al., 2019</xref>). In addition, a multilayered system containing some &#x201c;demon and angel&#x201d; kill-switches is a possible strategy to enhance genetic stability and reduce the survivor frequency (<xref ref-type="bibr" rid="B48">Torres et al., 2003</xref>; <xref ref-type="bibr" rid="B15">Gallagher et al., 2015</xref>; <xref ref-type="bibr" rid="B35">Nagasawa et al., 2024</xref>).</p>
<p>The &#x201c;demon and angel&#x201d; kill switch was designed to be highly resistant to point mutations and short insertion/deletion mutations, as described above. Surprisingly, the isolated loss-of-function mutants, P14R and P30R, acquired heavily deleted and substituted sequences in the <italic>tyrS</italic> regulatory region, suggesting that the large rearrangement of regulatory region is a serious obstacle. The following is an analysis and discussion of the underlying causes.</p>
<p>In the loss-of-function mutants, transcriptome analyses showed a significant decrease in the <italic>tyrS</italic> expression level upon IPTG induction although the native IPTG-inducible genes were normally upregulated. Re-transformation of the ASKA-(<italic>tyrS</italic>) plasmid isolated from the mutant reproduced the IPTG-resistant phenotype, indicating that the mutations in the plasmid were the main cause. NGS analyses detected substantial mutations in the regulatory region of the plasmidal <italic>tyrS</italic>, supporting this observation. In the mutated plasmids, the coliphage T5 promoter region was severely impaired, suggesting that the promoter activity substantially decreased. Additionally, the disruption of <italic>lacO</italic>
<sub>
<italic>1</italic>
</sub> embedded in the promoter sequence may mitigate the reduction in <italic>tyrS</italic> leakage expression. The sequence of the plasmidal <italic>tyrS</italic> regulatory region was completely identical between P14R and P30R, suggesting that P14R or its sister strain acquired further mutations in the genome and evolved into P30R. Based on the above observation, we propose a possible mechanism for the complex change of survivor frequency observed in the passage test. 1) Mutations in the ASKA plasmid reduced the activity of the promoter that controls the expression of <italic>tyrS</italic>, resulting in the severe decrease of <italic>tyrS</italic> expression in the ON state. The reduced level of TyrS failed to kill the host, causing the IPTG-resistance in P14R and P30R. 2) The weaker promoter activity and the <italic>lacO</italic>
<sub>
<italic>1</italic>
</sub> disruption also affected the <italic>tyrS</italic> leakage expression level. Overall, a similar level of <italic>tyrS</italic> expression in the OFF state was observed in both IPTG-sensitive and resistant strains, but the loss-of-function mutants had slightly higher fitness. Consequently, the proportion of the mutants gradually increased as the generation progressed. 3) Subsequently, the fraction of IPTG-resistant mutants decreased with the emergence of other mutants, such as P31S that was IPTG-sensitive and more rapidly grew, resulting in an increase in the total bacterial density as the frequency of the fast-growing mutants increased.</p>
<p>The loss-of-function mutants maintained <italic>tyrS</italic> expression levels in the OFF state, contributing to the higher fitness acquisition. To eliminate the fitness-advantage in the mutants, the expression level of the toxic essential gene should be adjusted to an optimal level in the bacteria harboring the functional kill-switch. This condition can be achieved by selecting and adjusting optimal genetic elements such as promoters, induction systems, RBSs, plasmid replication origins and toxic essential genes. P31S acquired a higher fitness, suggesting that evolutionary methods are also effective.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The RNA-seq data presented in the study are deposited in the DDBJ/ENA/GenBank repository, accession number PRJDB17547.</p>
</sec>
<sec id="s6">
<title>Author contributions</title>
<p>YK: Conceptualization, Funding acquisition, Investigation, Writing&#x2013;original draft. HM: Investigation, Resources, Writing&#x2013;review and editing.</p>
</sec>
<sec sec-type="funding-information" id="s7">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by JSPS grant number 20H03158.</p>
</sec>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s10">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbioe.2024.1365870/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fbioe.2024.1365870/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.PDF" id="SM1" mimetype="application/PDF" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baick</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Suk</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Dieter</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S. I.</given-names>
</name>
<name>
<surname>Eom</surname>
<given-names>S. H.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>Growth inhibition of <italic>Escherichia coli</italic> during heterologous expression of <italic>Bacillus subtilis</italic> glutamyl-tRNA synthetase that catalyzes the formation of mischarged glutamyl-tRNA<sub>1</sub>
<sup>Gln</sup>
</article-title>. <source>J. Microbiol.</source> <volume>42</volume>, <fpage>111</fpage>&#x2013;<lpage>116</lpage>.</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bedouelle</surname>
<given-names>H. U. G. U. E. S.</given-names>
</name>
<name>
<surname>Guez</surname>
<given-names>V. A. L. E. R. I. E.</given-names>
</name>
<name>
<surname>Vidal-Cros</surname>
<given-names>A. N. N. E.</given-names>
</name>
<name>
<surname>Hermann</surname>
<given-names>M. O. N. I. Q. U. E.</given-names>
</name>
</person-group> (<year>1990</year>). <article-title>Overproduction of tyrosyl-tRNA synthetase is toxic to <italic>Escherichia coli</italic>: a genetic analysis</article-title>. <source>J. Bacteriol.</source> <volume>172</volume>, <fpage>3940</fpage>&#x2013;<lpage>3945</lpage>. <pub-id pub-id-type="doi">10.1128/jb.172.7.3940-3945.1990</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ben-Asouli</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Banai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Pel-Or</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shir</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kaempfer</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Human interferon-&#x3b3; mRNA autoregulates its translation through a pseudoknot that activates the interferon-inducible protein kinase PKR</article-title>. <source>Cell.</source> <volume>108</volume>, <fpage>221</fpage>&#x2013;<lpage>232</lpage>. <pub-id pub-id-type="doi">10.1016/s0092-8674(02)00616-5</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhawsinghka</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Glenn</surname>
<given-names>K. F.</given-names>
</name>
<name>
<surname>Schaaper</surname>
<given-names>R. M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Complete genome sequence of <italic>Escherichia coli</italic> BL21-AI</article-title>. <source>Microbiol. Resour. Announc.</source> <volume>9</volume>, <fpage>e00009</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1128/mra.00009-20</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blazejewski</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>H. I.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H. H.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Synthetic sequence entanglement augments stability and containment of genetic information in cells</article-title>. <source>Science</source> <volume>365</volume>, <fpage>595</fpage>&#x2013;<lpage>598</lpage>. <pub-id pub-id-type="doi">10.1126/science.aav5477</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ellis</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Stan</surname>
<given-names>G. B.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Host-aware synthetic biology</article-title>. <source>Curr. Opin. Syst. Biol.</source> <volume>14</volume>, <fpage>66</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.coisb.2019.03.001</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bujard</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Gentz</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lanzer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Stueber</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mueller</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ibrahimi</surname>
<given-names>I.</given-names>
</name>
<etal/>
</person-group> (<year>1987</year>). <article-title>[26] A T5 promoter-based transcription-translation system for the analysis of proteins <italic>in vitro</italic> and <italic>in vivo</italic>
</article-title>. <source>Meth. Enzymol.</source> <volume>155</volume>, <fpage>416</fpage>&#x2013;<lpage>433</lpage>. <pub-id pub-id-type="doi">10.1016/0076-6879(87)55028-5</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chalker</surname>
<given-names>A. F.</given-names>
</name>
<name>
<surname>Ward</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Fosberry</surname>
<given-names>A. P.</given-names>
</name>
<name>
<surname>Hodgson</surname>
<given-names>J. E.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>Analysis and toxic overexpression in <italic>Escherichia coli</italic> of a staphylococcal gene encoding isoleucyl-tRNA synthetase</article-title>. <source>Gene</source> <volume>141</volume>, <fpage>103</fpage>&#x2013;<lpage>108</lpage>. <pub-id pub-id-type="doi">10.1016/0378-1119(94)90135-x</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chan</surname>
<given-names>C. T.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Cameron</surname>
<given-names>D. E.</given-names>
</name>
<name>
<surname>Bashor</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>J. J.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Deadman&#x27; and &#x27;Passcode&#x27; microbial kill switches for bacterial containment</article-title>. <source>Nat. Chem. Biol.</source> <volume>12</volume>, <fpage>82</fpage>&#x2013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.1979</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Datsenko</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Wanner</surname>
<given-names>B. L.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>One-step inactivation of chromosomal genes in <italic>Escherichia coli</italic> K-12 using PCR products</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>97</volume>, <fpage>6640</fpage>&#x2013;<lpage>6645</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.120163297</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deatherage</surname>
<given-names>D. E.</given-names>
</name>
<name>
<surname>Leon</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>&#xc1;. E.</given-names>
</name>
<name>
<surname>Omar</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Barrick</surname>
<given-names>J. E.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Directed evolution of <italic>Escherichia coli</italic> with lower-than-natural plasmid mutation rates</article-title>. <source>Nucleic Acids Res.</source> <volume>46</volume>, <fpage>9236</fpage>&#x2013;<lpage>9250</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gky751</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Denger</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Weiss</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Felux</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mayer</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Spiteller</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Sulphoglycolysis in <italic>Escherichia coli</italic> K-12 closes a gap in the biogeochemical sulphur cycle</article-title>. <source>Nature</source> <volume>507</volume>, <fpage>114</fpage>&#x2013;<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1038/nature12947</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fedorec</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Ozdemir</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Doshi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>Y. K.</given-names>
</name>
<name>
<surname>Rosa</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rutter</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Two new plasmid post-segregational killing mechanisms for the implementation of synthetic gene networks in <italic>Escherichia coli</italic>
</article-title>. <source>iScience</source> <volume>14</volume>, <fpage>323</fpage>&#x2013;<lpage>334</lpage>. <pub-id pub-id-type="doi">10.1016/j.isci.2019.03.019</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Freeman</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Gwadz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shore</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Molecular and genetic analysis of the toxic effect of RAP1 overexpression in yeast</article-title>. <source>Genetics</source> <volume>141</volume>, <fpage>1253</fpage>&#x2013;<lpage>1262</lpage>. <pub-id pub-id-type="doi">10.1093/genetics/141.4.1253</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gallagher</surname>
<given-names>R. R.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Interiano</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Rovner</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Isaacs</surname>
<given-names>F. J.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Multilayered genetic safeguards limit growth of microorganisms to defined environments</article-title>. <source>Nucl. acids Res.</source> <volume>43</volume>, <fpage>1945</fpage>&#x2013;<lpage>1954</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gku1378</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geng</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Leonard</surname>
<given-names>S. P.</given-names>
</name>
<name>
<surname>Mishler</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Barrick</surname>
<given-names>J. E.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Synthetic genome defenses against selfish DNA elements stabilize engineered bacteria against evolutionary failure</article-title>. <source>ACS Synth. Biol.</source> <volume>8</volume> (<issue>3</issue>), <fpage>521</fpage>&#x2013;<lpage>531</lpage>. <pub-id pub-id-type="doi">10.1021/acssynbio.8b00426</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hossain</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lopez</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Halper</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Cetnar</surname>
<given-names>D. P.</given-names>
</name>
<name>
<surname>Reis</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Strickland</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Automated design of thousands of nonrepetitive parts for engineering stable genetic systems</article-title>. <source>Nat. Biotechnol.</source> <volume>38</volume>, <fpage>1466</fpage>&#x2013;<lpage>1475</lpage>. <pub-id pub-id-type="doi">10.1038/s41587-020-0584-2</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ishikawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kojima</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hori</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Development of a biocontained toluene-degrading bacterium for environmental protection</article-title>. <source>Microbiol. Spectr.</source> <volume>9</volume>, <fpage>e0025921</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1128/spectrum.00259-21</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jing</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cost</surname>
<given-names>G. J.</given-names>
</name>
<name>
<surname>Chiang</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Kolpa</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Cotton</surname>
<given-names>A. M.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Translating dosage compensation to trisomy 21</article-title>. <source>Nature</source> <volume>500</volume>, <fpage>296</fpage>&#x2013;<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1038/nature12394</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kato</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>An engineered bacterium auxotrophic for an unnatural amino acid: a novel biological containment system</article-title>. <source>PeerJ</source> <volume>3</volume>, <fpage>e1247</fpage>. <pub-id pub-id-type="doi">10.7717/peerj.1247</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kato</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>An unnatural amino acid-regulated growth controller based on informational disturbance</article-title>. <source>Life</source> <volume>11</volume>, <fpage>920</fpage>. <pub-id pub-id-type="doi">10.3390/life11090920</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kato</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>A strategy for addicting transgene-free bacteria to synthetic modified metabolites</article-title>. <source>Front. Microbiol.</source> <volume>14</volume>, <fpage>1086094</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2023.1086094</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kitagawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ara</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Arifuzzaman</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ioka-Nakamichi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Inamoto</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Toyonaga</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>Complete set of ORF clones of <italic>Escherichia coli</italic> ASKA library (A complete set of <italic>E. coli</italic> K-12 ORF archive): unique Resources for biological research</article-title>. <source>DNA Res.</source> <volume>12</volume>, <fpage>291</fpage>&#x2013;<lpage>299</lpage>. <pub-id pub-id-type="doi">10.1093/dnares/dsi012</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hasty</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Stability, robustness, and containment: preparing synthetic biology for real-world deployment</article-title>. <source>Curr. Opin. Biotechnol.</source> <volume>79</volume>, <fpage>102880</fpage>. <pub-id pub-id-type="doi">10.1016/j.copbio.2022.102880</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lam</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Winkler</surname>
<given-names>M. E.</given-names>
</name>
</person-group> (<year>1992</year>). <article-title>Characterization of the complex <italic>pdxH-tyrS</italic> operon of <italic>Escherichia coli</italic> K-12 and pleiotropic phenotypes caused by <italic>pdxH</italic> insertion mutations</article-title>. <source>J. Bacteriol.</source> <volume>174</volume>, <fpage>6033</fpage>&#x2013;<lpage>6045</lpage>. <pub-id pub-id-type="doi">10.1128/jb.174.19.6033-6045.1992</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lanzer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bujard</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>1988</year>). <article-title>Promoters largely determine the efficiency of repressor action</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>85</volume>, <fpage>8973</fpage>&#x2013;<lpage>8977</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.85.23.8973</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liao</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Din</surname>
<given-names>M. O.</given-names>
</name>
<name>
<surname>Tsimring</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hasty</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Rock-paper-scissors: engineered population dynamics increase genetic stability</article-title>. <source>Science</source> <volume>365</volume>, <fpage>1045</fpage>&#x2013;<lpage>1049</lpage>. <pub-id pub-id-type="doi">10.1126/science.aaw0542</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lopatkin</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Meredith</surname>
<given-names>H. R.</given-names>
</name>
<name>
<surname>Srimani</surname>
<given-names>J. K.</given-names>
</name>
<name>
<surname>Pfeiffer</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Durrett</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>You</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Persistence and reversal of plasmid-mediated antibiotic resistance</article-title>. <source>Nat. Commun.</source> <volume>8</volume>, <fpage>1689</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-017-01532-1</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mandell</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Lajoie</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Mee</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Takeuchi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kuznetsov</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Norville</surname>
<given-names>J. E.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Biocontainment of genetically modified organisms by synthetic protein design</article-title>. <source>Nature</source> <volume>518</volume>, <fpage>55</fpage>&#x2013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1038/nature14121</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mathieu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Javed</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Vallet</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lesterlin</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Candusso</surname>
<given-names>M. P.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Functionality of membrane proteins overexpressed and purified from <italic>E. coli</italic> is highly dependent upon the strain</article-title>. <source>Sci. Rep.</source> <volume>9</volume>, <fpage>2654</fpage>&#x2013;<lpage>2715</lpage>. <pub-id pub-id-type="doi">10.1038/s41598-019-39382-0</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miano</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Hasty</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Inducible cell-to-cell signaling for tunable dynamics in microbial communities</article-title>. <source>Nat. Commun.</source> <volume>11</volume>, <fpage>1193</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-020-15056-8</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Min</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kitabatake</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Polycarpo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pelaschier</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Raczniak</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ruan</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>Protein synthesis in <italic>Escherichia coli</italic> with mischarged tRNA</article-title>. <source>J. Bacteriol.</source> <volume>185</volume>, <fpage>3524</fpage>&#x2013;<lpage>3526</lpage>. <pub-id pub-id-type="doi">10.1128/jb.185.12.3524-3526.2003</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mirande</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>1991</year>). <article-title>Aminoacyl-tRNA synthetase family from prokaryotes and eukaryotes: structural domains and their implications</article-title>. <source>Prog. Nucleic Acid. Res. Mol. Biol.</source> <volume>40</volume>, <fpage>95</fpage>&#x2013;<lpage>142</lpage>. <pub-id pub-id-type="doi">10.1016/s0079-6603(08)60840-5</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moe-Behrens</surname>
<given-names>G. H.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Haynes</surname>
<given-names>K. A.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Preparing synthetic biology for the world</article-title>. <source>Front. Microbiol.</source> <volume>4</volume>, <fpage>5</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2013.00005</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagasawa</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nakayama</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ogawa</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Aribam</surname>
<given-names>S. D.</given-names>
</name>
<name>
<surname>Tsugami</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>A novel vaccine strategy using quick and easy conversion of bacterial pathogens to unnatural amino acid-auxotrophic suicide derivatives</article-title>. <source>Microbiol. Spectr</source>.</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parker</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Lalanne</surname>
<given-names>J.-B.</given-names>
</name>
<name>
<surname>Kimura</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>G. E.</given-names>
</name>
<name>
<surname>Waldor</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>G.-W.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Growth-optimized aminoacyl-tRNA synthetase levels prevent maximal tRNA charging</article-title>. <source>Cell. Syst.</source> <volume>11</volume>, <fpage>121</fpage>&#x2013;<lpage>130.e6</lpage>. <pub-id pub-id-type="doi">10.1016/j.cels.2020.07.005</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piraner</surname>
<given-names>D. I.</given-names>
</name>
<name>
<surname>Abedi</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Moser</surname>
<given-names>B. A.</given-names>
</name>
<name>
<surname>Lee-Gosselin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Shapiro</surname>
<given-names>M. G.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Tunable thermal bioswitches for <italic>in vivo</italic> control of microbial therapeutics</article-title>. <source>Nat. Chem. Biol.</source> <volume>13</volume>, <fpage>75</fpage>&#x2013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.2233</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rottinghaus</surname>
<given-names>A. G.</given-names>
</name>
<name>
<surname>Ferreiro</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fishbein</surname>
<given-names>S. R.</given-names>
</name>
<name>
<surname>Dantas</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Moon</surname>
<given-names>T. S.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Genetically stable CRISPR-based kill switches for engineered microbes</article-title>. <source>Nat. Commun.</source> <volume>13</volume>, <fpage>672</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-022-28163-5</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruan</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Palioura</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sabina</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Marvin-Guy</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kochhar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>LaRossa</surname>
<given-names>R. A.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>Quality control despite mistranslation caused by an ambiguous genetic code</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>105</volume>, <fpage>16502</fpage>&#x2013;<lpage>16507</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0809179105</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schulte</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sterzenbach</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Miskiewicz</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Elpers</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hensel</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hansmeier</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>A versatile remote control system for functional expression of bacterial virulence genes based on the <italic>tetA</italic> promoter</article-title>. <source>Int. J. .Med. Microbiol.</source> <volume>309</volume>, <fpage>54</fpage>&#x2013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijmm.2018.11.001</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sebesta</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Guarnieri</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Biocontainment of genetically engineered algae</article-title>. <source>Front. Plant Sci.</source> <volume>13</volume>, <fpage>839446</fpage>. <pub-id pub-id-type="doi">10.3389/fpls.2022.839446</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skouloubris</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>de Pouplana</surname>
<given-names>L. R.</given-names>
</name>
<name>
<surname>De Reuse</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hendrickson</surname>
<given-names>T. L.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>A noncognate aminoacyl-tRNA synthetase that may resolve a missing link in protein evolution</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>100</volume>, <fpage>11297</fpage>&#x2013;<lpage>11302</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1932482100</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Son</surname>
<given-names>H. I.</given-names>
</name>
<name>
<surname>Weiss</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>You</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Design patterns for engineering genetic stability</article-title>. <source>Curr. Opin. Biomed. Eng.</source> <volume>19</volume>, <fpage>100297</fpage>. <pub-id pub-id-type="doi">10.1016/j.cobme.2021.100297</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sopko</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Preston</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Chua</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Papp</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kafadar</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2006</year>). <article-title>Mapping pathways and phenotypes by systematic gene overexpression</article-title>. <source>Mol. Cell.</source> <volume>21</volume>, <fpage>319</fpage>&#x2013;<lpage>330</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2005.12.011</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stirling</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bitzan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>O&#x2019;Keefe</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Redfield</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Oliver</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Way</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Rational design of evolutionarily stable microbial kill switches</article-title>. <source>Mol. Cell.</source> <volume>68</volume>, <fpage>686</fpage>&#x2013;<lpage>697.e3</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2017.10.033</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Su&#xe1;rez</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>Renda</surname>
<given-names>B. A.</given-names>
</name>
<name>
<surname>Dasgupta</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Barrick</surname>
<given-names>J. E.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Reduced mutation rate and increased transformability of transposon-free <italic>Acinetobacter baylyi</italic> ADP1-ISx</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>83</volume>, <fpage>e01025</fpage>&#x2013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1128/aem.01025-17</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swanson</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hoben</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Sumner-Smith</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Uemura</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>S&#xf6;ll</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>1988</year>). <article-title>Accuracy of <italic>in vivo</italic> aminoacylation requires proper balance of tRNA and aminoacyl-tRNA synthetase</article-title>. <source>Science</source> <volume>242</volume>, <fpage>1548</fpage>&#x2013;<lpage>1551</lpage>. <pub-id pub-id-type="doi">10.1126/science.3144042</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Torres</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Jaenecke</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Timmis</surname>
<given-names>K. N.</given-names>
</name>
<name>
<surname>Garc&#xed;a</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>D&#xed;az</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>A dual lethal system to enhance containment of recombinant micro-organisms</article-title>. <source>Microbiology</source> <volume>149</volume>, <fpage>3595</fpage>&#x2013;<lpage>3601</lpage>. <pub-id pub-id-type="doi">10.1099/mic.0.26618-0</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tramonti</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nardella</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>di Salvo</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Barile</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>D&#x2019;Alessio</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>de Cr&#xe9;cy-Lagard</surname>
<given-names>V.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Knowns and unknowns of vitamin B6 metabolism in <italic>Escherichia coli. EcoSal Plus</italic>
</article-title>. <source>EcoSal Plus</source> <volume>9</volume>, <fpage>eESP</fpage>. <pub-id pub-id-type="doi">10.1128/ecosalplus.esp-0004-2021</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Umenhoffer</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Feh&#xe9;r</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Balik&#xf3;</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ayaydin</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>P&#xf3;sfai</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Blattner</surname>
<given-names>F. R.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Reduced evolvability of <italic>Escherichia coli</italic> MDS42, an IS-less cellular chassis for molecular and synthetic biology applications</article-title>. <source>Microb. Cell. Factories</source> <volume>9</volume>, <fpage>38</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1186/1475-2859-9-38</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sleight</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Sauro</surname>
<given-names>H. M.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Rationally designed bidirectional promoter improves the evolutionary stability of synthetic genetic circuits</article-title>. <source>Nucleic Acids Res.</source> <volume>41</volume>, <fpage>e33</fpage>. <pub-id pub-id-type="doi">10.1093/nar/gks972</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tsui</surname>
<given-names>H. C. T.</given-names>
</name>
<name>
<surname>Man</surname>
<given-names>T. K.</given-names>
</name>
<name>
<surname>Winkler</surname>
<given-names>M. E.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Identification and function of the <italic>pdxY</italic> gene, which encodes a novel pyridoxal kinase involved in the salvage pathway of pyridoxal 5&#x2032;-phosphate biosynthesis in <italic>Escherichia coli</italic> K-12</article-title>. <source>J. Bacteriol.</source> <volume>180</volume>, <fpage>1814</fpage>&#x2013;<lpage>1821</lpage>. <pub-id pub-id-type="doi">10.1128/jb.180.7.1814-1821.1998</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>